How to Get Mounjaro: Who Qualifies, Legit Routes

To get Mounjaro you need a prescription for an approved use: type 2 diabetes and heart risk.

Prescription: RequiredFDA label (DailyMed)
Telehealth from, all in: $2,048 a month
Shortage: Resolved

Mounjaro in brief

How long it remains in your body

Its half-life runs about 5 days. Once 5 d pass, half is gone; five half-lives (25 d) leave about 3%.

Weight loss in the main trial

During a 40-week SURPASS-1 trial, people with type 2 diabetes lost 7.8 kg, versus 1 kg among those on placebo.

Price across time

The maker's price page gives the list price and self-pay offers, shown as monthly amounts in US dollars.

Sources: FDA label (DailyMed), healthsystemtracker.org, pricinginfo.lilly.com.

Mounjaro: all legitimate routes ranked

Ways to get it, arranged by price with the cheapest first
Route	Who it is for	What you pay
Your doctor, with insurance and the savings card	Commercial insurance that covers it	For a fill of up to 3 months, the cost can be as little as $25
Telehealth: Hims & Hers, Mounjaro	Online visit, medicine shipped	$2,048 a month all in

Prices checked November 2026. Each price links to its source page.

Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, FDA.

Who qualifies

Every GLP-1 sold in the US requires a prescription. A prescriber writes it when its use falls under an approved use on the label:

For people with type 2 diabetes aged 10 or older, it lowers blood sugar and is used alongside diet and exercise.
Among adults with type 2 diabetes who face a high risk, it reduces the chance of heart attack, stroke, or heart-related death.

FDA label (DailyMed) is required

Telehealth options compared

Programs offering Mounjaro through telehealth
Program	Medicine option	Medicine price	Membership	All in
Hims & Hers	Mounjaro	$1,899 a month	$149 a month after first month	$2,048 a month

Each program's prices come from its own pricing page. We make no money from any of them.

Source: hims.com.

Shortage status

Tirzepatide: the Shortage has been resolved. The FDA confirmed this on December 19, 2024.

First added to the FDA shortage list: December 15, 2022
Shortage resolved: December 19, 2024
State pharmacies had to end compounding of copies on February 18, 2025
Outsourcing facilities had to stop as of March 19, 2025

Source: FDA.

Scam signals

No prescription needed: in the US, a seller that skips this step is not a licensed pharmacy.
Compounded drugs sold as the brand: the FDA provides no approval for compounded drugs. None are Ozempic, Wegovy, Mounjaro or Zepbound.
Saying a product is the same as the brand: the FDA sent 30 warning letters to telehealth companies over misleading claims.
For compounded tirzepatide, the FDA has received over 730 adverse event reports.
The FTC acted against one program because its monthly price did not include the drug; see the NextMed review.

Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, FDA.

Where to get it in your state

All 50 states are not covered by Hims & Hers
All 50 states are not covered by Noom Med
Delivery through NovoCare Pharmacy reaches all 50 states, along with DC, Puerto Rico

The route changes the most under Medicaid rules. right now, GLP-1s for weight loss are covered by 10 state Medicaid programs. Select your state to view its drug list and any prior authorization requirements:

Sources: hims.com, noom.com, NovoCare.